Strategic Leadership and GMP Compliance: Demonstrated excellence in leading GMP-compliant production of sterile injectable vaccines. Successfully achieved EU Qualified Person (QP) standards for API production. Technology Transfer and Process Optimization: Conversion of the old facility into a GMP-compliant Peptide Vaccine Plant. Led the API peptide synthesis production line through technology transfer and process improvements, enhancing both productivity and quality standards. Led the aseptic injectable vaccine production line, implemented a production capacity expansion plan, completed the scale-up for technical batches ranging from 100L to 2000L.Global Collaboration and Communication: Experienced in international business relations, effectively communicating with international clients via phone, email, and conference meetings. Successfully collaborated with clients to expand the peptide vaccine market to South America, increasing the annual order quantity from less than 1 million doses to over 10 million doses.